Risk factors associated with drug-resistant Mycobacterium tuberculosis in Castilla-la-Mancha (Spain)

被引:22
作者
Arevalo, M
Solera, J
Cebrian, D
Bartolome, J
Robles, P
机构
[1] HOSP GEN ALBACETE,UNIDAD ENFERMEDADES INFECCIOSAS,E-02006 ALBACETE,SPAIN
[2] HOSP GEN ALBACETE,MED INTERNA SERV,E-02006 ALBACETE,SPAIN
[3] HOSP GEN ALBACETE,MICROBIOL LAB,E-02006 ALBACETE,SPAIN
关键词
drug resistance; risk factors; tuberculosis;
D O I
10.1183/09031936.96.09020274
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of this study was to investigate the incidence of primary and secondary resistance to antituberculosis drugs and the risk factors associated with the resistance in southeast Spain. Our research was based on the clinical histories of 276 patients, diagnosed as having tuberculosis by positive culture, who were tested for drug susceptibility between January 1988 and October 1994. The clinical histories were checked by two independent investigators. Drug-resistant strains were isolated from 24 patients (8-7%). Among the 239 patients without previous tuberculosis therapy, 7 (2.9%) were drug-resistant. Among the 37 patients with previous therapy, 17 (46%) were drug-resistant. Seventeen of the 276 patients (6.2%) had resistance to a single drug. Primary resistance to iso- niazid was 1.7%. Previous treatment for tuberculosis (odds ratio (OR) 39.2; 95% confidence interval (95% CI) 10.2-150); hepatic cirrhosis (OR 104; 95% CI 12.8-847); and age 45 yrs and older (OR 4.80; 95% CI 1.15-20.1) were considered risk factors associated with drug-resistant tuberculosis. We conclude that primary and secondary resistance is low in the southeast of Spain and we recommend that susceptibility testing be performed on initial M. tuberculosis isolated from patients with a history of previous tuberculosis therapy, hepatic cirrhosis or more than 44 yrs of age.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 30 条
[1]  
AITKEN ML, 1984, AM REV RESPIR DIS, V130, P831
[2]   CHARACTERISTICS OF PATIENTS WITH DRUG-RESISTANT AND DRUG-SENSITIVE TUBERCULOSIS IN EAST LONDON BETWEEN 1984 AND 1992 [J].
ALJARAD, N ;
PARASTATIDES, S ;
PAUL, EA ;
SHELDON, CD ;
GAYA, H ;
RUDD, RM ;
EMPEY, D .
THORAX, 1994, 49 (08) :808-810
[3]  
Alvarez D, 1994, Arch Bronconeumol, V30, P297
[4]  
ALVAREZ R, 1987, ENFERM INFEC MICR CL, V5, P343
[5]  
[Anonymous], 1994, EPI INFO VERSION 6 W
[6]  
Ausina V, 1990, Enferm Infecc Microbiol Clin, V8, P274
[7]   PROSPECTIVE-STUDY OF DRUG-RESISTANT TUBERCULOSIS IN A SPANISH URBAN-POPULATION INCLUDING PATIENTS AT RISK FOR HIV-INFECTION [J].
AUSINA, V ;
RIUTORT, N ;
VINADO, B ;
MANTEROLA, JM ;
MANZANO, JR ;
RODRIGO, C ;
MATAS, L ;
GIMENEZ, M ;
TOR, J ;
ROCA, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (02) :105-110
[8]   THE INFLUENCE OF EPIDEMIOLOGIC FACTORS ON DRUG-RESISTANCE RATES IN TUBERCULOSIS [J].
BARNES, PF .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (02) :325-328
[9]   HOSPITAL OUTBREAK OF MULTIDRUG-RESISTANT MYCOBACTERIUM-TUBERCULOSIS INFECTIONS - FACTORS IN TRANSMISSION TO STAFF AND HIV-INFECTED PATIENTS [J].
BECKSAGUE, C ;
DOOLEY, SW ;
HUTTON, MD ;
OTTEN, J ;
BREEDEN, A ;
CRAWFORD, JT ;
PITCHENIK, AE ;
WOODLEY, C ;
CAUTHEN, G ;
JARVIS, WR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (10) :1280-1286
[10]  
BENDOV I, 1987, AM REV RESPIR DIS, V135, P1307